CN115777842A - Functional pet food for improving activity of old pets and preparation method thereof - Google Patents
Functional pet food for improving activity of old pets and preparation method thereof Download PDFInfo
- Publication number
- CN115777842A CN115777842A CN202211540696.8A CN202211540696A CN115777842A CN 115777842 A CN115777842 A CN 115777842A CN 202211540696 A CN202211540696 A CN 202211540696A CN 115777842 A CN115777842 A CN 115777842A
- Authority
- CN
- China
- Prior art keywords
- freeze
- solution
- meat
- drying
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 title claims abstract description 30
- 235000013305 food Nutrition 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 235000013372 meat Nutrition 0.000 claims abstract description 65
- 238000004108 freeze drying Methods 0.000 claims abstract description 40
- 238000007710 freezing Methods 0.000 claims abstract description 15
- 238000005520 cutting process Methods 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 32
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 22
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 16
- 244000063299 Bacillus subtilis Species 0.000 claims description 16
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 16
- 238000001179 sorption measurement Methods 0.000 claims description 16
- 229920000858 Cyclodextrin Polymers 0.000 claims description 15
- 241001465754 Metazoa Species 0.000 claims description 15
- 241000193171 Clostridium butyricum Species 0.000 claims description 14
- 239000001116 FEMA 4028 Substances 0.000 claims description 14
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 14
- 229960004853 betadex Drugs 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 241000193749 Bacillus coagulans Species 0.000 claims description 13
- 241000194108 Bacillus licheniformis Species 0.000 claims description 13
- 239000001653 FEMA 3120 Substances 0.000 claims description 13
- 241001532059 Yucca Species 0.000 claims description 13
- 235000004552 Yucca aloifolia Nutrition 0.000 claims description 13
- 235000012044 Yucca brevifolia Nutrition 0.000 claims description 13
- 235000017049 Yucca glauca Nutrition 0.000 claims description 13
- 229940054340 bacillus coagulans Drugs 0.000 claims description 13
- 102000004882 Lipase Human genes 0.000 claims description 12
- 239000004367 Lipase Substances 0.000 claims description 12
- 108090001060 Lipase Proteins 0.000 claims description 12
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 12
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 12
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 12
- 235000013734 beta-carotene Nutrition 0.000 claims description 12
- 239000011648 beta-carotene Substances 0.000 claims description 12
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 12
- 229960002747 betacarotene Drugs 0.000 claims description 12
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 12
- 235000019421 lipase Nutrition 0.000 claims description 12
- 239000001656 lutein Substances 0.000 claims description 12
- 235000012680 lutein Nutrition 0.000 claims description 12
- 229960005375 lutein Drugs 0.000 claims description 12
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 12
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 12
- 235000012661 lycopene Nutrition 0.000 claims description 12
- 239000001751 lycopene Substances 0.000 claims description 12
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 12
- 229960004999 lycopene Drugs 0.000 claims description 12
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 12
- 229930182490 saponin Natural products 0.000 claims description 12
- 150000007949 saponins Chemical class 0.000 claims description 12
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 12
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 12
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 12
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 12
- 108091005804 Peptidases Proteins 0.000 claims description 11
- 239000004365 Protease Substances 0.000 claims description 11
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 11
- 229930003427 Vitamin E Natural products 0.000 claims description 11
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 11
- 235000019165 vitamin E Nutrition 0.000 claims description 11
- 229940046009 vitamin E Drugs 0.000 claims description 11
- 239000011709 vitamin E Substances 0.000 claims description 11
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000011259 mixed solution Substances 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims description 8
- 235000019419 proteases Nutrition 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 5
- -1 beta-cyclodextrin cyclic compound Chemical class 0.000 claims description 4
- 238000004945 emulsification Methods 0.000 claims description 4
- 239000008213 purified water Substances 0.000 claims description 4
- 235000015278 beef Nutrition 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 241000251468 Actinopterygii Species 0.000 claims description 2
- 241000272525 Anas platyrhynchos Species 0.000 claims description 2
- 241000287828 Gallus gallus Species 0.000 claims description 2
- 235000019688 fish Nutrition 0.000 claims description 2
- 235000015277 pork Nutrition 0.000 claims description 2
- 230000008014 freezing Effects 0.000 abstract description 10
- 241000282326 Felis catus Species 0.000 description 20
- 241000282472 Canis lupus familiaris Species 0.000 description 19
- 235000019629 palatability Nutrition 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 229940040461 lipase Drugs 0.000 description 9
- 238000004090 dissolution Methods 0.000 description 7
- 229920006395 saturated elastomer Polymers 0.000 description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000007363 ring formation reaction Methods 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- FAIFRACTBXWXGY-JTTXIWGLSA-N COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)[C@@]1(OC)C=C[C@@]35C[C@@H]1[C@](C)(O)CCc1ccccc1 Chemical compound COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)[C@@]1(OC)C=C[C@@]35C[C@@H]1[C@](C)(O)CCc1ccccc1 FAIFRACTBXWXGY-JTTXIWGLSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 235000014590 basal diet Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000003871 intestinal function Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 150000004666 short chain fatty acids Chemical class 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 206010034203 Pectus Carinatum Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000023011 digestive tract development Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 208000037817 intestinal injury Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 229960001518 levocarnitine Drugs 0.000 description 1
- 230000008604 lipoprotein metabolism Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Fodder In General (AREA)
Abstract
The invention discloses a functional pet food for improving activity of an elderly pet and a preparation method thereof. The preparation process comprises the steps of pre-freezing fresh meat, cutting according to the required specification, and carrying out first freeze-drying to obtain freeze-dried meat; mixing the rest raw materials to obtain an emulsified solution, immersing the freeze-dried meat in the solution, fully adsorbing the solution to saturation, and freeze-drying for the second time to obtain the finished product.
Description
Technical Field
The invention relates to the technical field of pet foods, in particular to a functional pet food for improving the activity of an elderly pet and a preparation method thereof.
Background
The lives of dogs and cats are generally 12-18 years old, and the dogs and cats enter the old age period after 7-8 years old, so that at present, experts predict that the number of old dogs and cats in 2025 years will reach 5000 ten thousand, the aging and aging process of old animals can generate free radicals, the free radicals can cause cell damage, so that the old animals lack vitality, and the vitality of the old animals can be remarkably improved by eliminating the free radicals.
The number of products added with functional components is not large in the market, but the products are mostly tablets, paste and granules. The paste has high moisture content, is easy to propagate harmful microorganisms, has the defects of unstable effective components, difficult storage, easy decay and flatulence, and has the problems of color change and the like in the storage process; the hardness of the tablet is high, so that the tablet is difficult to chew and has poor palatability for old dogs and cats; the granules need to be soaked in water for use, dogs and cats, particularly cats, do not like drinking water, and meanwhile, the granules resist drinking water for administration, so that the drug effect is reduced with the passage of time, and the special effect is difficult to play.
Therefore, the problem to be solved by those skilled in the art is how to provide a new form of functional pet food for improving the activity of an elderly pet.
Disclosure of Invention
In view of the above, the invention provides a functional pet food for improving the activity of an elderly pet and a preparation method thereof, which directly utilize the saturated adsorption characteristics of freeze-dried meat pieces on vitamin E, beta-carotene, lutein, lycopene, protease, lipase, L-carnitine, bacillus licheniformis, bacillus coagulans, clostridium butyricum, bacillus subtilis, isomaltooligosaccharide and yucca saponin to uniformly disperse active ingredients in the meat pieces, and freeze-dried meat pieces containing functional ingredients are formed by freeze-drying again to serve as a pet food for pets, particularly for improving the activity of the elderly pet.
In order to realize the purpose, the invention adopts the following technical scheme:
firstly, the invention provides a functional pet food for improving the activity of an elderly pet, which comprises the following raw materials in parts by weight:
70 to 95 portions of freeze-dried meat, 0.08 to 0.1 portion of vitamin E, 0.01 to 0.02 portion of beta-carotene, 0.02 to 0.03 portion of lutein, 0.07 to 0.1 portion of L-carnitine, 0.01 to 0.02 portion of lycopene, 1 to 2 portions of bacillus licheniformis, 1 to 2 portions of bacillus coagulans, 1 to 2 portions of bacillus subtilis, 1 to 2 portions of clostridium butyricum, 1 to 2 portions of isomalto-oligosaccharide, 0.05 to 0.15 portion of protease, 0.01 to 0.05 portion of lipase, 0.01 to 0.05 portion of yucca saponin and 0.05 to 0.20 portion of beta-cyclodextrin.
Vitamin E is fat-soluble and can protect unsaturated fatty acid in animal body from being damaged by free radical, and the unsaturated fatty acid has the function of protecting viscera;
beta-carotene supervises hypoxic parts, such as blood capillaries in muscles, so that the part with more blood capillaries, such as eyeballs and lungs, has the most protection effect, and each antioxidant has different parts with the best effect, and the two antioxidants are supplemented together to achieve the effect of comprehensively protecting the body;
the lutein can protect eyesight, resist oxidation and cancer, delay early arteriosclerosis and prevent diabetes;
l-carnitine promotes fat to be converted into energy vitamine, the vitamine has no toxic or side effect on pets, the most outstanding physiological function of the carnitine is to be used as a carrier for fatty acid transportation, medium-long chain fatty acid is transferred into a membrane from the outside of a cell mitochondrial membrane in the form of acetyl L-carnitine and is oxidized in a mitochondrial matrix to generate energy, the L-carnitine can shovel fat to enter a fuel furnace for combustion to provide energy, and the L-carnitine serves as the 'handling' of fat to mitochondria;
lycopene helps to keep healthy and active, enhance antioxidant and anti-inflammatory abilities of organism, protect cardiovascular and cerebrovascular vessels, protect skin, and enhance immunity;
the bacillus licheniformis promotes the growth of normal physiological anaerobes in the intestinal tract, regulates the imbalance of intestinal flora and recovers the intestinal function; can generate anti-active substances, has a unique biological oxygen-deprivation action mechanism, and can inhibit the growth and the reproduction of pathogenic bacteria;
the bacillus coagulans effectively inhibits the growth of harmful bacteria, improves the intestinal micro-ecological environment, promotes the intestinal development, enhances the intestinal function, has no toxic or side effect, is safe to use, can reduce harmful gases such as ammonia gas, hydrogen sulfide and the like in the environment, and improves the growth environment of pets. The strain content is high, all the strains are spores, and the strain is resistant to adverse environments such as high temperature and the like;
the clostridium butyricum has immunity and oxidation resistance, can regulate bone metabolism by influencing intestinal-brain axis mediators (hormone, short-chain fatty acid and neurotransmitter), promotes bone health, and has important significance for preventing leg diseases of pets;
the bacillus subtilis is stable and easy to store, and can be rapidly recovered and propagated after entering the intestinal tracts of animals. After the bacillus subtilis recovers and proliferates in animal intestinal tracts, the probiotic characteristics of the bacillus subtilis can be exerted, including the improvement of animal intestinal flora, the enhancement of organism immunity, the provision of various enzymes needed by animals and the like, the bacillus subtilis can make up the deficiency of endogenous enzymes in the animals, promotes the growth and development of the animals and has obvious probiotic effect;
the isomaltooligosaccharide can relieve constipation and optimize intestinal flora;
the protease can improve the nutritional characteristics and physiological functions of the protein; the lipase can act in synergy with other enzymes to catalyze and decompose oil and fat substances to generate saccharides; can be used for supplementing fat digestion deficiency caused by pancreatic lipase. Various lipases control the processes of digestion, absorption, fat reconstitution, lipoprotein metabolism, etc.;
the yucca saponin can obviously reduce the ammonia nitrogen index of pet feces, enhance the immunologic function and the antioxidant capacity, improve the jejunum form, regulate the nitrogen metabolism, increase the short-chain fatty acid content of intestinal tracts and regulate the intestinal microflora, and the yucca can also relieve the oxidative stress, the immunologic stress and the intestinal injury caused by ammonia stress and reduce the content of harmful bacteria in the intestinal tracts.
Preferably, the freeze-dried meat is one or more of chicken, duck, pork, beef and fish.
The invention also provides a preparation method of the functional pet food for improving the activity of the aged pet, which comprises the following steps:
(1) Pre-freezing fresh meat, cutting according to a required shape, and freeze-drying the cut meat blocks in a freeze-drying machine until the water content is less than or equal to 5%;
(2) Mixing beta-cyclodextrin and water according to a mass ratio of 1;
(3) Dissolving L-carnitine, bacillus licheniformis, bacillus coagulans, clostridium butyricum, bacillus subtilis, isomaltooligosaccharide and yucca saponin in the solution prepared in the step (2), and uniformly stirring the solution at the temperature of 15-25 ℃ to obtain a functional solution;
(4) And (2) adding the freeze-dried meat obtained in the step (1) into the functional solution obtained in the step (3), soaking for 10-30min to reach an adsorption saturation state, and freeze-drying to obtain the product.
Preferably, the meat cubes are in the shape of one or more of a cube, a cuboid, a cylinder, an animal shape and a heart.
Further, the weight of the meat blocks after freeze-drying is 1-2.5 +/-0.2 g/block.
Preferably, the lyophilization conditions in step (1) and step (4) are as follows: the vacuum degree is 10-30 Pa, the temperature is-30 to-40 ℃, and the time is 22-28 h.
According to the technical scheme, compared with the prior art, the invention discloses the functional pet food for improving the activity of the elderly pet and the preparation method thereof, and the functional pet food has the following beneficial effects:
the invention prepares the sample by a freeze-drying process, and is convenient to produce; the water content is low, and the product is stable; the addition of vitamins, beta-carotene, lutein, L-carnitine and lycopene can maintain or even improve age-related immunologic function reduction of various animals including dogs and cats, protect cardiovascular and cerebrovascular vessels, enhance oxidation resistance and anti-inflammatory capability and improve the activity of old pets; substances such as clostridium butyricum, bacillus licheniformis, bacillus coagulans, clostridium butyricum, bacillus subtilis and the like are added, so that the effects of regulating intestinal flora, enhancing intestinal health, repairing damaged intestinal mucosa and the like are achieved; the active ingredients subjected to cyclization treatment are uniformly dispersed in the meat blocks, so that the bioavailability is greatly improved; in addition, the invention uses standard meat blocks or meat strips, has better palatability, is suitable for quantitative feeding, is more convenient to feed, increases the interaction with pets, and promotes the emotion between owners and pets. The unique preparation process solves various problems of the pet supplementary food in the prior art, and the cyclodextrin cyclization process is used for carrying out cyclization treatment on 25-OH-D3 and VE, so that the bioavailability is obviously improved; the freeze-dried meat blocks are used as carriers, so that the palatability problem is completely solved, and the accurate quantitative supply of effective components is realized; functional components are uniformly dispersed through dissolution and adsorption, so that the use effect is improved; freeze-drying at low temperature to retain the activity of functional components to the maximum extent; the water content of the product is extremely low, and the shelf life is remarkably prolonged.
Detailed Description
The technical solutions of the present invention will be described clearly and completely with reference to the following embodiments of the present invention, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
A functional pet food for promoting activity of senior pet comprises the following raw materials: 378.76 g of fresh meat (weight after freeze-drying: 94.69 g), 0.08 g of vitamin E, 0.01 g of beta-carotene, 0.02 g of lutein, 0.07 g of L-carnitine, 0.01 g of lycopene, 1 g of Bacillus licheniformis (HJ 0135), 1 g of Bacillus coagulans (P-22): 1 g, bacillus subtilis (HJKC 01): 1 g, clostridium butyricum (HJDS 01): 1 g, isomaltooligosaccharide: 1 g, protease: 0.05 g, lipase: 0.01 g, yucca saponin: 0.01 g, beta-cyclodextrin: 0.05 g.
The preparation process comprises the following steps:
a. pre-freezing fresh meat, and cutting into 1 × 2 × 2-3 cm pieces 3 A rectangular parallelepiped (weighing about 2.3g after lyophilization);
b. putting the cut meat blocks into a freeze dryer, setting a freeze drying curve, starting the freeze dryer, continuously freeze-drying the meat blocks at the vacuum degree of 10-30 Pa in a freeze drying box at the freeze drying temperature of-30-40 ℃ until the moisture content is lower than 5%;
c. mixing beta-cyclodextrin and water according to a mass ratio of 1 to 200 until the solution is clarified, then adding vitamin E, beta-carotene, lutein, lycopene, protease, lipase and 40kHZ for ultrasonic emulsification to clarify to form a beta-cyclodextrin cyclic compound of the mixed solution, then adding 2 times of purified water by volume of the mixed solution to form an emulsified solution, then dissolving L-carnitine, bacillus licheniformis, bacillus coagulans, clostridium butyricum, bacillus subtilis, isomaltooligosaccharide and yucca saponin in the solution, and uniformly stirring, wherein the temperature of the solution is kept between 15 and 25 ℃;
d. pouring the prepared functional solution into an open container to form a depth capable of soaking the freeze-dried meat blocks, adding the freeze-dried meat blocks, and soaking the freeze-dried meat blocks in the solution for 10-30min to ensure that the freeze-dried meat blocks reach an adsorption saturation state;
e. and c, repeating the step b for secondary freeze-drying on the meat blocks with saturated adsorption to obtain a finished product, wherein the weight of each tablet of the finished product is 2.5 +/-0.2 g.
The fresh meat is chicken breast.
In the pre-freezing step, the freezing temperature of the meat blocks is-18 ℃, and the freezing time is more than 5 h.
In the freeze-drying step, the freeze-drying time of the meat blocks is 22h each time.
In the dissolution step, the dissolution temperature was 15 ℃.
In the adsorption step, the freeze-dried meat blocks are completely immersed in the solution until a saturated adsorption state is reached.
Example 2
A functional pet food for improving activity of senior pets comprises the following raw materials:
378.76 g of fresh meat (weight after freeze-drying: 94.69 g), 0.08 g of vitamin E, 0.01 g of beta-carotene, 0.02 g of lutein, 0.07 g of L-carnitine, 0.01 g of lycopene, 1 g of Bacillus licheniformis (HJ 0135), 1 g of Bacillus coagulans (P-22): 1 g, bacillus subtilis (HJKC 01): 1 g, clostridium butyricum (HJDS 01): 1 g, isomaltooligosaccharide: 1 g, protease: 0.05 g, lipase: 0.01 g, yucca saponin: 0.01 g, beta-cyclodextrin: 0.05 g;
the preparation method comprises the following steps:
a. pre-freezing fresh meat, cutting into 1 × 2 × 2-3 cm pieces 3 (weight about 2.3g after lyophilization) rectangular parallelepiped;
b. putting the cut meat blocks into a freeze dryer, setting a freeze drying curve, starting the freeze dryer, continuously freeze-drying the meat blocks at the vacuum degree of 10-30 Pa in a freeze drying box at the freeze drying temperature of-30-40 ℃ until the moisture content is lower than 5%;
c. mixing beta-cyclodextrin and water according to a mass ratio of 1 to 200 until the solution is clarified, then adding vitamin E, beta-carotene, lutein, lycopene, protease, lipase and 40kHZ for ultrasonic emulsification to clarify to form a beta-cyclodextrin cyclic compound of the mixed solution, then adding purified water with 2 times of the volume of the mixed solution to form an emulsified solution, then dissolving L-carnitine, bacillus licheniformis, bacillus coagulans, clostridium butyricum, bacillus subtilis, isomalto-oligosaccharide and yucca saponin in the solution, and uniformly stirring, wherein the temperature of the solution is kept between 15 and 25 ℃;
d. pouring the prepared functional solution into an open container to form a depth capable of soaking the freeze-dried meat blocks, adding the freeze-dried meat blocks, and soaking the freeze-dried meat blocks in the solution for 10-30min to ensure that the freeze-dried meat blocks reach an adsorption saturation state;
e. and (c) repeating the step (b) to freeze-dry the meat blocks with saturated adsorption for the second time to obtain a finished product.
The fresh meat is salmon meat.
In the quick-freezing step, the quick-freezing temperature of the meat blocks is-18 ℃, and the quick-freezing time is more than 5 hours.
In the freeze-drying step, the time for freeze-drying the meat blocks is 22h each time.
In the dissolution step, the dissolution temperature was 15 ℃.
In the adsorption step, the freeze-dried meat pieces are immersed in the solution until adsorption is completely saturated.
Example 3
A functional pet food for improving activity of senior pets comprises the following raw materials:
378.76 g of fresh meat (weight after freeze-drying: 94.69 g), 0.08 g of vitamin E, 0.01 g of beta-carotene, 0.02 g of lutein, 0.07 g of L-carnitine, 0.01 g of lycopene, 1 g of Bacillus licheniformis (HJ 0135), 1 g of Bacillus coagulans (P-22): 1 g, bacillus subtilis (HJKC 01): 1 g, clostridium butyricum (HJDS 01): 1 g, isomaltooligosaccharide: 1 g, protease: 0.05 g, lipase: 0.01 g, yucca saponin: 0.01 g, beta-cyclodextrin: 0.05 g;
the preparation method comprises the following steps:
a. pre-freezing fresh meat, and cutting into 1 × 2 × 2-3 cm pieces 3 A rectangular parallelepiped (weighing about 2.3g after lyophilization);
b. putting the cut meat blocks into a freeze dryer, setting a freeze-drying curve, starting the freeze dryer, and continuously freeze-drying the meat blocks at the vacuum degree of 10-30 Pa in a freeze-drying box at the freeze-drying temperature of-30-40 ℃ until the moisture content is lower than 5%;
c. mixing beta-cyclodextrin and water according to a mass ratio of 1 to 200 until the solution is clarified, then adding vitamin E, beta-carotene, lutein, lycopene, protease, lipase and 40kHZ for ultrasonic emulsification to clarify to form a beta-cyclodextrin cyclic compound of the mixed solution, then adding 2 times of purified water by volume of the mixed solution to form an emulsified solution, then dissolving L-carnitine, bacillus licheniformis, bacillus coagulans, clostridium butyricum, bacillus subtilis, isomaltooligosaccharide and yucca saponin in the solution, and uniformly stirring, wherein the temperature of the solution is kept between 15 and 25 ℃;
d. pouring the prepared functional solution into an open container to a depth capable of soaking the freeze-dried meat blocks, adding the freeze-dried meat blocks, and soaking the freeze-dried meat blocks in the solution for 20min to ensure that the freeze-dried meat blocks reach an adsorption saturation state;
e. and c, repeating the step b to perform secondary freeze-drying on the meat blocks with saturated adsorption to obtain a finished product. The weight of the finished product is 2.5 g +/-0.3 g per tablet.
The fresh meat is beef.
In the pre-freezing step, the freezing temperature of the meat blocks is-18 ℃, and the pre-freezing time is more than 5 hours.
In the freeze-drying step, the vacuum drying time of each meat block is 22h.
In the dissolution step, the dissolution temperature was 15 ℃.
In the adsorption step, the freeze-dried meat pieces are completely immersed in the solution until the adsorption is completely saturated.
Test example 1
Dog palatability testing of the product
The test method comprises the following steps: selecting 7 pet dogs, placing the paste 1 sold in the market and the tablet 1 sold in the market on three identical plates on the first day, and observing pet dog selection; the next day three identical plates were placed with example 2, commercially available paste 1, commercially available tablet 1, respectively, and pet dog selection was observed; on the third day, three identical plates were placed with example 3, commercially available paste 1, commercially available tablet 1, respectively, and pet dog selection was observed;
dog palatability studies are shown in table 1.
TABLE 1 dog palatability
Test example 2
Cat palatability testing of the product was performed
The test method comprises the following steps: selecting 7 pet cats, placing the pet cats in the same three dishes on the first day, respectively placing the pet cats in the example 1, the commercially available paste 1 and the commercially available tablet 1, and observing the selection of the pet cats; next day three identical plates were placed with each of example 2, commercially available paste 1, commercially available tablet 1, and pet cat selection was observed; on the third day, three identical plates were placed with example 3, commercially available paste 1, commercially available tablet 1, respectively, and pet cat selection was observed;
cat palatability study is shown in table 2.
TABLE 2 Cat palatability
The results show that: analysis according to palatability results: the functional food for pets, which is made of the freeze-dried meat, has far better palatability to dogs and cats than paste and tablets with the same functions.
Test example 3
Reaction test of pet functional food to external stimulus of aged pet dog
The test method comprises the following steps: selecting 30 old dogs with slow movement, slow reaction and lack of vitality, dividing into 6 groups, feeding basal diet at 8 o ' clock, 12 o ' clock and 17 o ' clock each day, feeding 110g each time, and providing clean drinking water. The first group was fed example 1; the second group was fed example 2; the third group was fed example 3; feeding commercially available ointment 1 to the fourth group; feeding the fifth group with commercially available tablet 1, feeding all tested products at 14 o' clock each day, and continuously feeding for 60 days; the sixth group was a blank control group fed only basal ration. All dogs were carefully observed and tested prior to the start of the trial.
The feeding amount and the activity state before and after feeding of the six groups of dogs are shown in the following table:
test analysis of pet dogs: compared with a blank control group, the feed of the same kind of products can obviously enhance the response to external stimulation, effectively enhance the perception of the old animals to the outside, provide basic conditions for the old animals to make activity enhancing response, and the effect of the product on improving the activity of the old pets is better than that of the same kind of products sold in the market.
Test example 4
Behavior change test of pet functional food on pet cat
The test method comprises the following steps: 30 pet cats which are reluctant to frequently move in daily life in the advanced age period are selected and divided into 6 groups, basic daily ration is fed at 8 o ' clock, 12 o ' clock and 17 o ' clock each day, 40 g is fed each time, and clean drinking water is provided. The first group was fed example 1; the second group was fed example 2; the third group was fed example 3; feeding commercially available paste 1 to the fourth group; feeding the fifth group with commercially available tablet 1 at 14 o' clock each day for 60 days; the sixth group was fed a blank control group, fed basal diet only. All cats were carefully observed and tested prior to the start of the test.
The feeding amount and the activity state before and after feeding of six groups of cats are shown in the table below:
the pet cat test results show that: compared with a blank control group, the similar products fed by the pet feeding device are not afraid of change, and are more likely to interact with people, and the effect of the product on improving the activity of the elderly pets is better than that of the similar products sold in the market.
In the present specification, the embodiments are described in a progressive manner, each embodiment focuses on differences from other embodiments, and the same and similar parts among the embodiments are referred to each other. The device disclosed by the embodiment corresponds to the method disclosed by the embodiment, so that the description is simple, and the relevant points can be referred to the method part for description.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (6)
1. A functional pet food for improving activity of an elderly pet is characterized by comprising the following raw materials in parts by weight:
70 to 95 portions of freeze-dried meat, 0.08 to 0.1 portion of vitamin E, 0.01 to 0.02 portion of beta-carotene, 0.02 to 0.03 portion of lutein, 0.07 to 0.1 portion of L-carnitine, 0.01 to 0.02 portion of lycopene, 1 to 2 portions of bacillus licheniformis, 1 to 2 portions of bacillus coagulans, 1 to 2 portions of bacillus subtilis, 1 to 2 portions of clostridium butyricum, 1 to 2 portions of isomalto-oligosaccharide, 0.05 to 0.15 portion of protease, 0.01 to 0.05 portion of lipase, 0.01 to 0.05 portion of yucca saponin and 0.05 to 0.20 portion of beta-cyclodextrin.
2. The functional pet food for improving the vitality of senior pets according to claim 1, wherein the freeze-dried meat is one or more of chicken, duck, pork, beef, and fish.
3. A method of preparing a functional pet food for enhancing the vitality of senior pets according to any one of claims 1 to 2, comprising the steps of:
(1) Pre-freezing fresh meat, cutting according to a required shape, and freeze-drying the cut meat blocks in a freeze-drying machine until the water content is less than or equal to 5%;
(2) Mixing beta-cyclodextrin and water according to the mass ratio of 1 to 200 until the solution is clear, then adding vitamin E, beta-carotene, lutein, lycopene, protease and lipase, carrying out ultrasonic emulsification at 40kHZ to clarify to form a beta-cyclodextrin cyclic compound of the mixed solution, and then adding purified water with 2 times of volume of the mixed solution to form an emulsified solution;
(3) Dissolving L-carnitine, bacillus licheniformis, bacillus coagulans, clostridium butyricum, bacillus subtilis, isomaltooligosaccharide and yucca saponin in the solution prepared in the step (2), and uniformly stirring the solution at the temperature of 15-25 ℃ to obtain a functional solution;
(4) And (2) adding the freeze-dried meat obtained in the step (1) into the functional solution obtained in the step (3), soaking for 10-30min to reach an adsorption saturation state, and freeze-drying to obtain the product.
4. The method of claim 3, wherein the meat mass is in the shape of one or more of a cube, cuboid, cylinder, animal, or heart.
5. The method of claim 4, wherein the meat pieces have a weight of 1-2.5 ± 0.2 g/piece after lyophilization.
6. The method for preparing a functional pet food for improving the vitality of senior pets according to claim 3, wherein the freeze-drying conditions in the steps (1) and (4) are as follows: the vacuum degree is 10-30 Pa, the temperature is-30 to-40 ℃, and the time is 22-28 h.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211540696.8A CN115777842A (en) | 2022-12-02 | 2022-12-02 | Functional pet food for improving activity of old pets and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211540696.8A CN115777842A (en) | 2022-12-02 | 2022-12-02 | Functional pet food for improving activity of old pets and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115777842A true CN115777842A (en) | 2023-03-14 |
Family
ID=85445130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211540696.8A Pending CN115777842A (en) | 2022-12-02 | 2022-12-02 | Functional pet food for improving activity of old pets and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115777842A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7211280B1 (en) * | 1999-09-09 | 2007-05-01 | Nestec S.A. | Condition of elderly pets |
| US7368481B1 (en) * | 2002-09-27 | 2008-05-06 | Rapisarda Family Irrevocable Trust | Pet anti-aging wellness supplement for cats |
| CN108323641A (en) * | 2018-02-07 | 2018-07-27 | 上海宠幸宠物用品有限公司 | A kind of health food and preparation method thereof for improving pet dog cat function of intestinal canal |
| KR102061431B1 (en) * | 2018-11-27 | 2019-12-31 | 박명자 | Manufacturing method of a healthy and funtional foods for pet and the healthy and funtional foods for pet by the same |
| CN114208966A (en) * | 2022-01-18 | 2022-03-22 | 金卫 | Pet probiotic health-care food |
-
2022
- 2022-12-02 CN CN202211540696.8A patent/CN115777842A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7211280B1 (en) * | 1999-09-09 | 2007-05-01 | Nestec S.A. | Condition of elderly pets |
| US7368481B1 (en) * | 2002-09-27 | 2008-05-06 | Rapisarda Family Irrevocable Trust | Pet anti-aging wellness supplement for cats |
| CN108323641A (en) * | 2018-02-07 | 2018-07-27 | 上海宠幸宠物用品有限公司 | A kind of health food and preparation method thereof for improving pet dog cat function of intestinal canal |
| KR102061431B1 (en) * | 2018-11-27 | 2019-12-31 | 박명자 | Manufacturing method of a healthy and funtional foods for pet and the healthy and funtional foods for pet by the same |
| CN114208966A (en) * | 2022-01-18 | 2022-03-22 | 金卫 | Pet probiotic health-care food |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Francis et al. | Dietary supplementation with a Quillaja saponin mixture improves growth performance and metabolic efficiency in common carp (Cyprinus carpio L.) | |
| Abd El-Hack et al. | Organic or inorganic zinc in poultry nutrition: a review | |
| CN104206859B (en) | Antibiotic-free feed for fattening pigs and preparation method thereof | |
| CN106562038B (en) | Functional feed for improving pork quality | |
| CN103330059B (en) | Health care composition for livestock as well as preparation method and application thereof | |
| 횜zsoy | The effects of dietary supplementation of L-carnitine and humic substances on performance, egg traits and blood parameters in laying hens | |
| CN107996823A (en) | Composite probiotic fermented feed and its preparation method and application | |
| RU2420565C1 (en) | Method of producing biological product for mycotoxin elimination from raw feed and biological product produced by such method | |
| CN105211651A (en) | Feed feed and the production method thereof of wild boar children pig | |
| Toutou et al. | Growth performance and biochemical blood parameters of Nile tilapia, Oreochromis niloticus, and thinlip mullet, Liza ramada, fed a diet supplemented with lemon (Citrus aurantifolia) peel in a polyculture system | |
| RU2366271C1 (en) | Forage additive as preventive and treatment medium for domestic and farm animals | |
| CN115777842A (en) | Functional pet food for improving activity of old pets and preparation method thereof | |
| CN114903128B (en) | Crayfish compound feed and preparation method thereof | |
| KR20070031815A (en) | Feed additive and livestock bred by the feed additive | |
| Fokkink et al. | Selenium yeast for dairy calf feeds | |
| CN111700158A (en) | Composition with garlic residue as carrier and application thereof | |
| KR100886623B1 (en) | Method for feed hens a breeding | |
| E Hussein et al. | Effects of dietary potassium diformate (KDF) on growth performance and immunity of the sea bass, Dicentrarchus labrax, reared in hapas | |
| CN111149918A (en) | Composition of green disease-free yield-increasing cultivation technology and application | |
| Mousavi et al. | Economic comparison of conventional feedlot method with creep feeding in Afshari male lambs | |
| KR101613440B1 (en) | Manufacturing methods of probiotics comprising garlic husk | |
| Ibatullin et al. | Influence of soy flour and its processed products on the essential amino acids content in the bees body | |
| Smolentsev et al. | Stimulation of agricultural poultry productivity by using biologically active additives | |
| KR20190001118A (en) | Supplementary feed containing detoxified sulfur and manufacturing method thereof | |
| JPH0466530B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |